Need For Detox growth despite the reduction in Big Pharma

The 40,000 jobs lost, and it expects to reduce the more they shrink in Big Pharma. But before you breathe a sigh of relief, reductions occurring in the industry, large pharmaceutical companies are most likely to need the program more, not less, for the detoxification of prescription drugs.

Some players are selling large pharmaceutical companies, pharmaceutical companies and other cutting less profitable. An article in the Guardian Unlimited, Switzerland> The pharmaceutical group Novartis AG has a layoff of 2,500 workers - and this is just the latest wave of desperate measures to save Big Pharma. A week ago, Bristol-Myers Squibb has announced cuts to unload 10 percent of the work and close some plants, and the French pharmaceutical company Sanofi-Aventis has announced that spending. All other major players have already taken steps to address shrinking margins, including Pfizer, AstraZeneca, Merck, GlaxoSmithKline, AmgenSchering-Plough, Eli Lilly and Johnson & Johnson.

Drug Recall

Big pharma cuts the answer to the problems of the industry with several new drugs, new drugs, because it can not be required to provide the research laboratories. Many cost effective to replace branded drugs due to patent in the coming years, nothing. Competition from generic drugs grows, so, like patents, trademarks popular generic drugs. Nunless the only drugs cheaper, it would mean only an increase in demand for detoxification of drugs, people are increasingly depending on requirements.

Need For Detox growth despite the reduction in Big Pharma

Drugs, the "black box" warnings are not affected by the FDA or have been withdrawn because of the risks, costs billions of dollars in Big Pharma. Required for liquidation of thousands of people in drug rehabilitation, some, not to mention the casualties in a morgue. Physicians and patients, no drugs, includingLike those who have not withdrawn.

For example, Merck withdrew its arthritis painkiller Vioxx from the market in 2004 because of serious cardiovascular adverse events. aware of the risk - but a survey found that using 47% of patients taking Vioxx if we were to remain on the market! But the former Vioxx users in the next half to do all these rules, including Celebrex, Pfizer - the only drug Vioxx, and yet allowedU.S. market, but a clear warning. Merck Vioxx lost the turnover 2500000000 $, but 60% of drug users has decreased security issues Celebrex. Before the withdrawal of Vioxx, Celebrex should have won in 2005 and now receives only $ 4,000,000,000 $ 2,000,000,000 a year ago from the sale of the world.

Now, a generation of new drugs unknown side effects and possible addiction. The smaller, so-called "biotech" companiesBig Pharma does not continue, the pharmaceutical industry of new drugs, including major damage to the bottom line, adding that the list of drugs and drug rehabilitation centers may also apply.

It appears that detoxification drug required will continue to grow despite the economic crisis Nagy drugs. In fact, the growth of the drug was rapid detoxification, as before, due to cheaper generic brands much. Millions of people alreadyaccording to the safety of prescription drugs net is no different than a detoxification. But the decline in value of patents for medical devices increasingly demand a drug detoxification program, the cultures of prescription drugs, not less comfortable.

Need For Detox growth despite the reduction in Big Pharma

Tapeworm Symptoms Temperpedic Pillow Liquid Ionic Minerals